Literature DB >> 33279483

Can the Absence of Hypertension Refine the Risk Assessment of Older Adults for Future Cardiovascular Events?

Michael G Nanna1, Ann Marie Navar2, Daniel Wojdyla3, Adam J Nelson3, Alex E Sullivan4, Eric D Peterson2.   

Abstract

We sought to determine if the absence of hypertension in older adults can be used to identify those at lower risk of atherosclerotic cardiovascular disease (ASCVD). We identified participants ≥75 years old free of cardiovascular disease (CVD) in the National Institutes of Health Pooled Cohorts with and without hypertension. We assessed the association between systolic blood pressure (BP), diastolic BP, and cardiovascular events using multivariable modeling. The association between predicted ASCVD risk and observed events was compared. Of 2,667 adults aged ≥75 years, 67.9% had hypertension. Lower systolic BP correlated with lower CVD event rates. ASCVD predicted risk score and systolic BP were both independently associated with ASCVD event rates. Among adults with similar ASCVD predicted risk estimates, those without (vs with) hypertension had lower observed event rates across the predicted risk spectrum. The absence of hypertension may help refine the risk stratification of older adults, particularly those with intermediate predicted risk.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33279483      PMCID: PMC8221431          DOI: 10.1016/j.amjcard.2020.11.027

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  26 in total

1.  An approach to longitudinal studies in a community: the Framingham Study.

Authors:  T R DAWBER; W B KANNEL; L P LYELL
Journal:  Ann N Y Acad Sci       Date:  1963-05-22       Impact factor: 5.691

2.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

Review 3.  Hypertension Management in Older and Frail Older Patients.

Authors:  Athanase Benetos; Mirko Petrovic; Timo Strandberg
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

4.  The Cardiovascular Health Study: design and rationale.

Authors:  L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman
Journal:  Ann Epidemiol       Date:  1991-02       Impact factor: 3.797

Review 5.  Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis.

Authors:  H D Intengan; E L Schiffrin
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

6.  Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

Authors:  Jeff D Williamson; Mark A Supiano; William B Applegate; Dan R Berlowitz; Ruth C Campbell; Glenn M Chertow; Larry J Fine; William E Haley; Amret T Hawfield; Joachim H Ix; Dalane W Kitzman; John B Kostis; Marie A Krousel-Wood; Lenore J Launer; Suzanne Oparil; Carlos J Rodriguez; Christianne L Roumie; Ronald I Shorr; Kaycee M Sink; Virginia G Wadley; Paul K Whelton; Jeffrey Whittle; Nancy F Woolard; Jackson T Wright; Nicholas M Pajewski
Journal:  JAMA       Date:  2016-06-28       Impact factor: 56.272

7.  A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.

Authors:  Martin Bødtker Mortensen; Valentin Fuster; Pieter Muntendam; Roxana Mehran; Usman Baber; Samantha Sartori; Erling Falk
Journal:  J Am Coll Cardiol       Date:  2016-08-30       Impact factor: 24.094

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study.

Authors:  Wolfgang Lieb; Martin G Larson; Emelia J Benjamin; Xiaoyan Yin; Geoffrey H Tofler; Jacob Selhub; Paul F Jacques; Thomas J Wang; Joseph A Vita; Daniel Levy; Ramachandran S Vasan; Gary F Mitchell
Journal:  Circulation       Date:  2008-12-22       Impact factor: 29.690

Review 10.  Evaluation and treatment of older patients with hypercholesterolemia: a clinical review.

Authors:  Timo E Strandberg; Laura Kolehmainen; Alpo Vuorio
Journal:  JAMA       Date:  2014-09-17       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.